Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
4.140
+1.230 (42.27%)
At close: Sep 26, 2025, 4:00 PM EDT
4.490
+0.350 (8.45%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Applied DNA Sciences Employees
As of September 30, 2024, Applied DNA Sciences had 48 total employees, including 46 full-time and 2 part-time employees. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$77,980
Profits / Employee
$847,396
Market Cap
5.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
APDN News
- 4 days ago - Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences - Accesswire
- 6 weeks ago - Applied DNA Reports Third Quarter Fiscal 2025 Financial Results - Accesswire
- 2 months ago - Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - Accesswire
- 2 months ago - Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Accesswire
- 3 months ago - Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx - Accesswire
- 3 months ago - Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - Accesswire
- 3 months ago - Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August - Accesswire
- 4 months ago - Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Accesswire